'Hide-then-hit' to explain the importance of genotypic polymorphism of DNA repair genes in determining susceptibility to cancer

Journal of Molecular Cell Biology

Volumn 3, Issue 1, 2011, Pages 59-65

  Wu, Pei Ei ^a   Shen, Chen Yang ^a,b  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

DNA repair; Genotype; Polymorphism

Indexed keywords

EID: 79951471338     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjq054     Document Type: Article

References (40)

1. Allen, C., Kurimasa, A., Brenneman, M. A., et al. (2002). DNA-dependent protein kinase suppresses double-strand break-induced and spontaneous homologous recombination. Proc. Natl. Acad. Sci. USA 99, 3758-3763. (Pubitemid 34252179)
2. Attardi, L. D. (2005). The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models. Mutat. Res. 569, 145-157. (Pubitemid 39643264)
3. Balmain, A., Gray, J., and Ponder, B. (2003). The genetics and genomics of cancer. Nat. Genet. 33, 238-244. (Pubitemid 36278834)
4. Cheng, T. C., Chen, S. T., Yu, J. C., et al. (2005). Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int. J. Cancer 113, 345-353.
5. Concannon, P. (2002). ATM heterozygosity and cancer risk. Nat. Genet. 32, 89-90. (Pubitemid 34977201)
6. Couedel, C., Mills, K. D., Barchi, M., et al. (2004). Collaboration of homologous recombination and nonhomologous end-joining factors for the survival and integrity of mice and cells. Genes Dev. 18, 1293-1304. (Pubitemid 38720597)
7. Dickson, R. B., and Stancel, G. M. (2000). Estrogen receptor-mediated processes in normal and cancer cells. J. Natl. Cancer Inst. Monogr. 27, 135-145.
8. Ding, S. L., Yu, J. C., Chen, S. T., et al. (2009). Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. Carcinogenesis 30, 43-49.
9. Ding, S. L., Yu, J. C., Chen, S. T., et al. (2010). Diverse associations between ESR1 polymorphism and breast cancer development and progression. Clin. Cancer Res. 16, 3473-3484.
10. Elledge, S. J., and Amon, A. (2002). The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients. Cancer Cell 1, 129-132. (Pubitemid 41039159)
11. Falck, J., Petrini, J. H., Williams, B. R., et al. (2002). The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat. Genet. 30, 290-294.
12. Foulkes, W. D. (2008). Inherited susceptibility to common cancers. N. Engl. J. Med. 359, 2143-2153.
13. Fu, Y. P., Yu, J. C., Cheng, T. C., et al. (2003). Breast cancer risk associated with genotypic polymorphism of the non-homologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res. 63, 2440-2446.
14. Gompel, A., Somai, S., Chaouat, M., et al. (2000). Hormonal regulation of apoptosis in breast cells and tissues. Steroids 65, 593-598.
15. Greenblatt, M. S., Chappuis, P. O., Bond, J. P., et al. (2001). TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. Cancer Res. 61, 4092-4097. (Pubitemid 32720976)
16. Hosgood, H. D., 3rd., Menashe, I., Shen, M., et al. (2008). Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis 29, 1938-1943.
17. Hsu, H. M., Wang, H. C., Chen, S. T., et al. (2007). Breast cancer risk is associated with the genes encoding the DNA double-strand-break repair Mre11/Rad50/Nbs1 complex. Cancer Epidemiol. Biomarkers Prev. 16, 2024-2032.
18. Hu, Z., Ma, H., Chen, F., et al. (2005). XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomarkers Prev. 14, 1810-1818. (Pubitemid 40995099)
19. Karran, P. (2000). DNA double strand break repair in mammalian cells. Curr. Opin. Genet. Dev. 10, 144-150. (Pubitemid 30182246)
20. Khanna, K. K., and Jackson, S. P. (2001). DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27, 247-254. (Pubitemid 32201842)
21. Kinzler, K. W., and Vogelstein, B. (1997). Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386, 761-763.
22. Knudson, A. G., Jr. (1971). Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68, 820-823.
23. Lau, A., Kanaar, R., Jackson, S. P., et al. (2004). Suppression of retroviral infection by the RAD52 DNA repair protein. EMBO J. 23, 3421-3429. (Pubitemid 39209165)
24. Meek, D. W. (2009). Tumour suppression by p53: a role for the DNA damage response? Nat. Rev. Cancer 9, 714-723.
25. Michiels, S., Laplanche, A., Boulet, T., et al. (2009). Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk. Carcinogenesis 30, 763-768.
26. Narod, S. A. (2002). Modifiers of risk of hereditary breast and ovarian cancer. Nat. Rev. Cancer 2, 113-123. (Pubitemid 37328798)
27. O'Donovan, P. J., and Livingston, D. M. (2010). BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA doublestrand break repair. Carcinogenesis 31, 961-967.
28. O'Driscoll, M., Cerosaletti, K. M., Girard, P. M., et al. (2001). DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell 8, 1175-1185. (Pubitemid 34084990)
29. O'Driscoll, M., Gennery, A. R., Seidel, J., et al. (2004). An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome. DNA Repair 3, 1227-1235. (Pubitemid 38997966)
30. Otterson, G. A., Kratzke, R. A., Coxon, A., et al. (1994). Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wild type Rb. Oncogene 9, 3375-3378.
31. Pharoah, P. D., Antoniou, A., Bobrow, M., et al. (2002). Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet. 3, 33-36.
32. Rahman, N., and Stratton, M. R. (1998). The genetics of breast cancer susceptibility. Annu. Rev. Genet. 32, 95-121. (Pubitemid 29045309)
33. Shapiro, G. I., Edwards, C. D., Kobzik, L., et al. (1995). Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res. 55, 505-509.
34. Shen, C. Y., Yu, J. C., Lo, Y. L., et al. (2000). Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma-an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res. 60, 3884-3892.
35. Sherr, C. J. (2004). Principles of tumor suppression. Cell 116, 235-246. (Pubitemid 38167315)
36. van Gent, D. C., Hoeijmakers, J. H. J., and Kanaar, R. (2001). Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet. 2, 196-206. (Pubitemid 33674018)
37. Vodicka, P., Stetina, R., Polakova, V., et al. (2007). Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis 28, 657-664. (Pubitemid 46523361)
38. Vogelstein, B., and Kinzler, K. W. (2002). The Genetic Basis of Human Cancer. New York: McGraw-Hill.
39. Wang, X., Szabo, C., Qian, C., et al. (2008). Mutational analysis of thirty-two double-strand DNA break repair genes in breast and pancreatic cancers. Cancer Res. 68, 971-975. (Pubitemid 351272213)
40. Yu, J. C., Ding, S. L., Chang, C. H., et al. (2009). Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. Carcinogenesis 30, 1562-1570.